Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review
Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products in therapeutic areas such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, neurological, ophthalmic, malaria, cancer, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.
Cipla Ltd Key Recent Developments
Jul 31,2021: Cipla Provides Annual Report 2020-21 for 31st Jul 2021
Jul 31,2021: Cipla announce Financial Statements of Subsidiaries FY 2020-21 31st Jul 2021
Jun 30,2021: Indian pharma companies partner to trial molnupiravir for Covid-19
Jun 30,2021: Cipla announces appointment of director
Jun 30,2021: Cipla Announces Notice of 85th Annual General Meeting
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products in therapeutic areas such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, neurological, ophthalmic, malaria, cancer, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.
Cipla Ltd Key Recent Developments
Jul 31,2021: Cipla Provides Annual Report 2020-21 for 31st Jul 2021
Jul 31,2021: Cipla announce Financial Statements of Subsidiaries FY 2020-21 31st Jul 2021
Jun 30,2021: Indian pharma companies partner to trial molnupiravir for Covid-19
Jun 30,2021: Cipla announces appointment of director
Jun 30,2021: Cipla Announces Notice of 85th Annual General Meeting
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Cipla Ltd - Key Facts
Cipla Ltd - Key Employees
Cipla Ltd - Key Employee Biographies
Cipla Ltd - Major Products and Services
Cipla Ltd - History
Cipla Ltd - Company Statement
Cipla Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Cipla Ltd - Business Description
Business Segment: New Ventures
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: South Africa
Performance
Geographical Segment: United States of America
Performance
R&D Overview
Cipla Ltd - Corporate Strategy
Cipla Ltd - SWOT Analysis
SWOT Analysis - Overview
Cipla Ltd - Strengths
Cipla Ltd - Weaknesses
Cipla Ltd - Opportunities
Cipla Ltd - Threats
Cipla Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cipla Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jul 31, 2021: Cipla Provides Annual Report 2020-21 for 31st Jul 2021
Jul 31, 2021: Cipla announce Financial Statements of Subsidiaries FY 2020-21 31st Jul 2021
Jun 30, 2021: Indian pharma companies partner to trial molnupiravir for Covid-19
Jun 30, 2021: Cipla announces appointment of director
Jun 30, 2021: Cipla Announces Notice of 85th Annual General Meeting
May 14, 2021: Cipla : Appointment of director
Apr 28, 2021: Merck signs licensing deals with five Indian firms for Oral Covid-19 drug
Mar 23, 2021: Cipla Therapeutics and SIGA Technologies announce strategic partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Mar 23, 2021: Cipla Therapeutics: Intimation of re-appointment of managing director
Mar 02, 2021: Cipla Gulf expands partnership with Alvotech for commercialization of biosimilars in Australia and New Zealand
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Cipla Ltd - Key Facts
Cipla Ltd - Key Employees
Cipla Ltd - Key Employee Biographies
Cipla Ltd - Major Products and Services
Cipla Ltd - History
Cipla Ltd - Company Statement
Cipla Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Cipla Ltd - Business Description
Business Segment: New Ventures
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: South Africa
Performance
Geographical Segment: United States of America
Performance
R&D Overview
Cipla Ltd - Corporate Strategy
Cipla Ltd - SWOT Analysis
SWOT Analysis - Overview
Cipla Ltd - Strengths
Cipla Ltd - Weaknesses
Cipla Ltd - Opportunities
Cipla Ltd - Threats
Cipla Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cipla Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jul 31, 2021: Cipla Provides Annual Report 2020-21 for 31st Jul 2021
Jul 31, 2021: Cipla announce Financial Statements of Subsidiaries FY 2020-21 31st Jul 2021
Jun 30, 2021: Indian pharma companies partner to trial molnupiravir for Covid-19
Jun 30, 2021: Cipla announces appointment of director
Jun 30, 2021: Cipla Announces Notice of 85th Annual General Meeting
May 14, 2021: Cipla : Appointment of director
Apr 28, 2021: Merck signs licensing deals with five Indian firms for Oral Covid-19 drug
Mar 23, 2021: Cipla Therapeutics and SIGA Technologies announce strategic partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Mar 23, 2021: Cipla Therapeutics: Intimation of re-appointment of managing director
Mar 02, 2021: Cipla Gulf expands partnership with Alvotech for commercialization of biosimilars in Australia and New Zealand
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Cipla Ltd, Key Facts
Cipla Ltd, Key Employees
Cipla Ltd, Key Employee Biographies
Cipla Ltd, Major Products and Services
Cipla Ltd, History
Cipla Ltd, Subsidiaries
Cipla Ltd, Affiliate
Cipla Ltd, Joint Venture
Cipla Ltd, Key Competitors
Cipla Ltd, Ratios based on current share price
Cipla Ltd, Annual Ratios
Cipla Ltd, Annual Ratios (Cont...1)
Cipla Ltd, Annual Ratios (Cont...2)
Cipla Ltd, Interim Ratios
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cipla Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Cipla Ltd, Key Facts
Cipla Ltd, Key Employees
Cipla Ltd, Key Employee Biographies
Cipla Ltd, Major Products and Services
Cipla Ltd, History
Cipla Ltd, Subsidiaries
Cipla Ltd, Affiliate
Cipla Ltd, Joint Venture
Cipla Ltd, Key Competitors
Cipla Ltd, Ratios based on current share price
Cipla Ltd, Annual Ratios
Cipla Ltd, Annual Ratios (Cont...1)
Cipla Ltd, Annual Ratios (Cont...2)
Cipla Ltd, Interim Ratios
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cipla Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Cipla Ltd, Performance Chart (2017 - 2021)
Cipla Ltd, Ratio Charts
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Cipla Ltd, Performance Chart (2017 - 2021)
Cipla Ltd, Ratio Charts
Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021